1
|
Ignatius MS, Hayes MN, Moore FE, Tang Q, Garcia SP, Blackburn PR, Baxi K, Wang L, Jin A, Ramakrishnan A, Reeder S, Chen Y, Nielsen GP, Chen EY, Hasserjian RP, Tirode F, Ekker SC, Langenau DM. tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish. eLife 2018; 7:37202. [PMID: 30192230 PMCID: PMC6128690 DOI: 10.7554/elife.37202] [Citation(s) in RCA: 39] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2018] [Accepted: 08/22/2018] [Indexed: 12/22/2022] Open
Abstract
The TP53 tumor-suppressor gene is mutated in >50% of human tumors and Li-Fraumeni patients with germ line inactivation are predisposed to developing cancer. Here, we generated tp53 deleted zebrafish that spontaneously develop malignant peripheral nerve-sheath tumors, angiosarcomas, germ cell tumors, and an aggressive Natural Killer cell-like leukemia for which no animal model has been developed. Because the tp53 deletion was generated in syngeneic zebrafish, engraftment of fluorescent-labeled tumors could be dynamically visualized over time. Importantly, engrafted tumors shared gene expression signatures with predicted cells of origin in human tissue. Finally, we showed that tp53del/del enhanced invasion and metastasis in kRASG12D-induced embryonal rhabdomyosarcoma (ERMS), but did not alter the overall frequency of cancer stem cells, suggesting novel pro-metastatic roles for TP53 loss-of-function in human muscle tumors. In summary, we have developed a Li-Fraumeni zebrafish model that is amenable to large-scale transplantation and direct visualization of tumor growth in live animals.
Collapse
Affiliation(s)
- Myron S Ignatius
- Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.,Center of Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts.,Harvard Stem Cell Institute, Boston, Massachusetts.,Department of Molecular Medicine, Greehey Children's Cancer Research Institute, San Antonio, Texas
| | - Madeline N Hayes
- Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.,Center of Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts.,Harvard Stem Cell Institute, Boston, Massachusetts
| | - Finola E Moore
- Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.,Center of Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts.,Harvard Stem Cell Institute, Boston, Massachusetts
| | - Qin Tang
- Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.,Center of Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts.,Harvard Stem Cell Institute, Boston, Massachusetts
| | - Sara P Garcia
- Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts
| | - Patrick R Blackburn
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States
| | - Kunal Baxi
- Department of Molecular Medicine, Greehey Children's Cancer Research Institute, San Antonio, Texas
| | - Long Wang
- Department of Molecular Medicine, Greehey Children's Cancer Research Institute, San Antonio, Texas
| | - Alexander Jin
- Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts
| | - Ashwin Ramakrishnan
- Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts
| | - Sophia Reeder
- Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts
| | - Yidong Chen
- Department of Molecular Medicine, Greehey Children's Cancer Research Institute, San Antonio, Texas
| | - Gunnlaugur Petur Nielsen
- Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.,Center of Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts
| | - Eleanor Y Chen
- Department of Pathology, University of Washington, Seattle, United States
| | - Robert P Hasserjian
- Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.,Center of Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts
| | - Franck Tirode
- Department of Translational Research and Innovation, Université Claude Bernard Lyon, Cancer Research Center of Lyon, Lyon, France
| | - Stephen C Ekker
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, United States
| | - David M Langenau
- Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.,Center of Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts.,Harvard Stem Cell Institute, Boston, Massachusetts
| |
Collapse
|
2
|
Jin X, Xu Y, Zhang J, Li G, Huang D, Yang Y, He H. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement. Diagn Pathol 2017. [PMID: 28623913 PMCID: PMC5474018 DOI: 10.1186/s13000-017-0636-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
Background Aggressive natural killer cell leukemia/lymphoma (ANKL) is a rare and highly aggressive NK cell neoplasm with a short clinical course and poor prognosis and is often misdiagnosed and confused with NK/T cell lymphoma (NKTL), which has a very different prognosis. Here, we present a case with nasal and bone marrow involvement, provide a literature review and make a differential diagnosis. Case presentation A 41-year-old male presented nasal congestion pharyngalgia, palatal perforation, high fever and multiorgan dysfunction. Our diagnosis primarily relied on clinical features, the morphology and immunophenotype of the neoplastic cells and imaging studies. Characteristic large granular lymphocytes with azurophilic granules were visible in the bone marrow smears. In addition, the neoplastic cells expressed a typical immunophenotype, and the T cell receptor γ (TCR-γ) gene rearrangement analysis and presence of Epstein-Barr virus (EBV) were negative. The patient’s symptoms and signs were temporarily relieved after chemotherapy treatment, but after a short time, he underwent a rapid clinical decline and died 8 weeks later after admission due to multiorgan function failure. Conclusion Our case demonstrates that to avoid a misdiagnosis, bone marrow analyses and other examinations should be performed early when a patient initially presents nasal lesions and other systemic symptoms. To the best of our knowledge, this may be the first reported case of ANKL with sternal tenderness.
Collapse
Affiliation(s)
- Xiaoke Jin
- Laboratory of Hematopathology, Department of Hematology, the Affiliated Yijishan Hospital of Wannan Medical College, Wuhu, 241000, China
| | - Youhai Xu
- Department of Hematology, the Affiliated Yijishan Hospital of Wannan Medical College, Zheshan West Road, Wuhu, 241000, China
| | - Jun Zhang
- Laboratory of Hematopathology, Department of Hematology, the Affiliated Yijishan Hospital of Wannan Medical College, Wuhu, 241000, China
| | - Guangxi Li
- Laboratory of Hematopathology, Department of Hematology, the Affiliated Yijishan Hospital of Wannan Medical College, Wuhu, 241000, China
| | - Dongping Huang
- Department of Hematology, the Affiliated Yijishan Hospital of Wannan Medical College, Zheshan West Road, Wuhu, 241000, China
| | - Yuqiong Yang
- Department of Hematology, the Affiliated Yijishan Hospital of Wannan Medical College, Zheshan West Road, Wuhu, 241000, China
| | - Hesheng He
- Department of Hematology, the Affiliated Yijishan Hospital of Wannan Medical College, Zheshan West Road, Wuhu, 241000, China.
| |
Collapse
|
3
|
Matzen SMH, Kallenbach K, Reumert AR, Munksgaard L. Aggressive NK-cell leukemia in a 69 years old Caucasian woman: a case report. SPRINGERPLUS 2015; 4:763. [PMID: 26682116 PMCID: PMC4673078 DOI: 10.1186/s40064-015-1553-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/28/2015] [Accepted: 11/24/2015] [Indexed: 12/24/2022]
Abstract
Aggressive NK-cell leukemia is a rare malignancy mostly seen in younger Asians with a rapid clinical course and poor prognosis. Here, we describe a 69 years old Caucasian woman presenting with massive leukemization of neoplastic NK-cells. The cells were abnormal in morphology and surface marker expression and this clearly distinguished them from their normal counterpart. They were large and variable in shapes with irregular folding of the nuclei. By flow cytometry, their light scatter characteristics resembled normal monocytes. They showed bright expression of CD56 and CD2 but markedly decreased expression of CD7. They also expressed CD25. The patient presented with general malaise, including high fever, abdominal pain, signs and haemophagocytosis, and she quickly deteriorated and died 11 days after hospitalization. The origin of the leukemic cells of aggressive NK-cell leukemia is most likely the relatively scarce population of CD56bright NK-cells, primarily residing lymph nodes and tonsils. The immunophenotype of the case presented here support this, adding CD25 expression which is not earlier addressed in this entity.
Collapse
Affiliation(s)
- Sara Maj Hyldig Matzen
- Department of Clinical Biochemistry, Copenhagen University Hospital Roskilde, Koegevej 7-13, 4000 Roskilde, Denmark
| | - Klaus Kallenbach
- Department of Clinical Pathology, Copenhagen University Hospital Roskilde, Koegevej 7-13, 4000 Roskilde, Denmark
| | - Anne Regitze Reumert
- Department of Clinical Biochemistry, Copenhagen University Hospital Roskilde, Koegevej 7-13, 4000 Roskilde, Denmark
| | - Lars Munksgaard
- Department of Hematology, Copenhagen University Hospital Roskilde, Koegevej 7-13, 4000 Roskilde, Denmark
| |
Collapse
|
4
|
Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients - preliminary study. Cent Eur J Immunol 2015; 40:354-9. [PMID: 26648781 PMCID: PMC4655387 DOI: 10.5114/ceji.2015.54599] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2015] [Accepted: 08/19/2015] [Indexed: 01/18/2023] Open
Abstract
Background Fingolimod is a drug administered orally to adult patients treated for relapsing remitting course of multiple sclerosis (MS). Mode of action of fingolimod is based on intense S1P1 receptor stimulation and “arresting” lymphocytes in lymphatic organs. Objective of the research was to assess changes in the frequencies of basic lymphocyte subsets in patients treated for multiple sclerosis with the use of fingolimod. Material and methods Study group comprised of 25 previously untreated adult patients with MS. Venous blood samples were collected from each patient before and one month, three months and six months after treatment initiation. Peripheral blood lymphocyte immunophenotype was assessed with a set of monoclonal antibodies bounded to appropriate fluorochromes and flow cytometer FACSC alibur. Statistical analysis of the results was conducted using Statistica 9.0 software. Results Before fingolimod administration median of lymphocyte subsets percentage in each patient was in reference range. After 1 month of treatment we noticed significant changes in frequencies of following lymphocyte subsets: NK cells – 51.22% (p = 0.016), T CD4+ cells – 11.58% (p = 0.01), T CD4+:T CD8+ cells ratio – 0.61 (p = 0.005). After 3 and 6 months of treatment there was further increase of deviation from normal state. Conclusions The use of fingolimod is associated with profound changes in lymphocyte subsets distribution, which might bear a risk of the development of cellular immune deficiency symptoms.
Collapse
|